Sumatriptan-induced changes in plasma calcitonin gene-related peptide (CGRP)
concentration and headache intensity were investigated in 19 female migraineurs during …

Increasing knowledge about the role of calcitonin gene-related peptide (CGRP) in migraine
pathophysiology has led to the development of antibodies against this peptide or its …

Background: There is ongoing debate about whether the oculomotor (III), trochlear (IV), or
abducens (VI) nerve paresis in patients with migraine is directly attributable to migraine …

We aimed to evaluate the response rate of migraines by using anti-calcitonin gene-related
peptide (anti-CGRP) for patients with migraines. We searched three main medical …

Migraine is a common neurological disorder that afflicts up to 15% of the adult population in
most countries, with predominance in females. It is characterized by episodic, often disabling …

The neuropeptide calcitonin gene‐related peptide (CGRP) is implicated in the underlying
pathology of migraine. Serum levels of CGRP, which are elevated during a migraine attack …

Objective Calcitonin gene-related peptide (CGRP) receptor antagonists have been
suggested as novel treatments for acute migraine. This study aimed to use meta-analysis to …

Objective To review the role of CGRP in human models of primary headaches and to
discuss methodological aspects and future directions. Discussion Provocation experiments …

Background: Calcitonin gene-related peptide (CGRP) is involved in the pathophysiology of
migraine and cluster headache. Whether CGRP has any role in chronic tension-type …

Objective Migraine, endometriosis, and the comorbidity of both are frequent pain disorders
of special relevance for women. The neuropeptide calcitonin gene‐related peptide (CGRP) …